HNSCC cell lines with high Bcl-xL expression demonstrated an inferior response to chemotherapy or ionizing radiation and even turned out to be associated with poor clinical outcomes [27,28]. This evidence concerns the gene BCL2L1 and head and neck squamous cell carcinoma.